Tag archive for ‘JMP Securities’
Globes On Thursday, July 31st, 2014

VBL Therapeutics prices Nasdaq IPO

– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing of its Nasdaq IPO. The company is selling More...

Globes On Sunday, October 27th, 2013

Alcobra Raises $33 Million In Secondary Nasdaq Offering

– The ADHD treatment developer raised $27 million in its IPO in May. –     Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) raised a gross $33 million in its secondary offering on Thursday. More...

Wordpress site Developed by Fixing WordPress Problems